Kaplan-Meier survival analysis demonstrated that CRC patients with low SLC44A2 expression had significantly poorer survival rates and higher recurrence rates compared to those with high SLC44A2 expression (Fig. 1G and H). This evidence concerns the gene SLC44A2 and colorectal carcinoma.